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Hypersensitivity Pneumonitis in Workers
Exposed to Metalworking Fluids
Christopher M. Barber, MD,1 Clare M. Burton, MD,1 David J. Hendrick, MD,2
C Anthony C. Pickering, MD,3 Alastair S. Robertson, MD,4 Wendy Robertson, PhD,5
and P Sherwood Burge, MD6
Background This study used data from a large UK outbreak investigation, to develop and
validate a new case definition for hypersensitivity pneumonitis due to metalworking fluid
exposure (MWF-HP).
Methods The clinical data from all workers with suspectedMWF-HPwere reviewed by an
experienced panel of clinicians. A new MWF-HP Score was then developed to match the
“gold standard” clinical opinion as closely as possible, using standard diagnostic criteria
that were relatively weighted by their positive predictive value.
Results The new case definition was reproducible, and agreed with expert panel opinion
in 30/37 cases. This level of agreement was greater than with any of the three previously
utilized case definitions (agreement in 16–24 cases). Where it was possible to calculate, the
MWF-HP Score also performed well when applied to 50 unrelated MWF-HP cases.
Conclusions The MWF-HP Score offers a new case definition for use in future outbreaks.
Am. J. Ind. Med. 57:872–880, 2014.  2014 The Authors. American Journal of Industrial
Medicine Published by Wiley Periodicals, Inc. This is an open access article under the terms of the
Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and
distribution in any medium, provided the original work is properly cited, the use is non-
commercial and no modifications or adaptations are made.
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INTRODUCTION
Hypersensitivity pneumonitis (HP) is an allergic lung
disease, most commonly caused by inhalation of proteins or
chemicals at home or in the workplace. The presenting
symptoms of HP can be non-specific, and vary with acute,
sub-acute or chronic forms of disease.
A new cause of HP was first recognized in the United
States in 1990s [Bernstein et al., 1995; Kreiss and Cox-
Ganser, 1997], and despite a number of detailed workplace
investigations, cases continue to be reported due to exposure
to metalworking fluid mists (MWFs) [Rosenman, 2009].
ModernMWFs are complex mixtures of oil and water that are
used as coolants and lubricants in a wide-range of industries.
Although the exact cause of the outbreaks remains
elusive [Burton et al., 2012], it is thought that the re-
circulation of the MWFs leading to microbiological
contamination is most likely to be responsible [Barber
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et al., 2011, 2013]. The outbreaks ofMWF-HP that have been
reported from the US [Mirer, 2010], UK [Robertson
et al., 2007], and France [Tillie-Leblond et al., 2011], have
usually involved workplaces with several hundred exposed
workers. Investigating the cause of symptoms among such a
large workforce is logistically challenging, and a range of
case definitions have therefore previously been developed
and utilized [Zacharisen et al., 1998; Fox et al., 1999;
Hodgson et al., 2001; Dangman et al., 2002; Weiss
et al., 2002; Gupta and Rosenman, 2006; Robertson
et al., 2007]. Little comparative data exists however
[Dangman et al., 2002], and no single case definition has
emerged as an accepted standard to allow comparisons
between future outbreaks [Barber et al., 2012].
The aim of this study was to use existing data from a
largeUK investigation of an outbreak [Robertson et al., 2007]
to develop a simple and inclusive case definition for MWF-
HP, and attempt to validate it by applying it to cases from
unrelated outbreaks.
MATERIALS AND METHODS
In the absence of any validated method of diagnosing
MWF-HP, this study utilized the clinical opinion of an expert
panel of occupational respiratory disease consultants as the
diagnostic “gold standard.”
Case Selection
In 2003–2004, a large outbreak of respiratory ill health
was investigated in three phases, at Powertrain, an
automobile engine manufacturing plant in Birmingham
UK. In total 37/808 workers were suspected of having
MWF-HP and/or humidifier fever, with 19 workers going on
to meet a case definition for HP [Robertson et al., 2007]. The
main study population for this project comprised all of the 37
workers recorded as having suspected HP and/or humidifier
fever), following assessment by the clinical team at
Birmingham Chest Clinic during Phase 3 of the outbreak
investigation (Fig. 1).
Selection of Expert Panel
The panel comprised five consultants selected from the
UK Group of Occupational Respiratory Disease Specialists
(GORDS). This included two members (PSB/ASR) who had
been involved both in the outbreak investigation, and clinical
follow-up of affected workers at Birmingham Chest Clinic.
The third member (CACP) had assisted in the outbreak
investigation, but not the clinical follow-up of affected
workers. The fourth and fifth members (DJH/CMB) had not
participated in the investigation or follow-up of workers.
Expert Panel Meeting
The panel reviewed hospital records and clinical data
documented during the outbreak investigation and subse-
quent hospital follow-up for each worker. This included
predicted lung function measures previously calculated
utilizing the European Steel and Coal Community reference
equations [Cotes et al., 1993; Quanjer et al., 1993]. Following
discussion of each case, individual panel member indepen-
dently recorded their clinical opinion as to whether there was
sufficient clinical evidence to classify the patient as a definite
case, a possible case, or definitely not a case ofMWF-HP. The
panel was not provided with any information during the
meeting relating to whether each case had previously met the
case definition of HP used at the time of the outbreak
investigation. A definite clinical case of MWF-HP required at
least four of the panel members to agree. Similarly MWF-HP
was excluded where at least four panel members agreed it was
definitely not a case. Any other combination of opinions
resulted in a possible case of MWF-HP. An Expert Panel
Percentage (EPP range 0–100%) was calculated for each
case, representing how likely it was that this represented
MWF-HP. This was calculated based on the total of five
scores, where each definite opinion equaled 20%, each
possible opinion equaled 10%, and each definitely not
opinion equaled 0%.
Reproducibility
In order to assess the reproducibility of the panel opinion,
10 randomly selected cases were re-presented for review,
with the panel being blinded to their previous opinion.
Results from the first and second opinion were compared.
Reproducibility of the EPP was calculated using the
concordance correlation coefficient.
MWF-HP Case Definition Development
Based on the opinion of the panel, the 37 workers with
suspected MWF-HP during the outbreak investigation, were
divided into two groups based on whether they had been
classified as a definite clinical case, or not. Demographic and
clinical data were compared between these groups. Continu-
ous data were compared using Student t-tests, and categorical
data were compared using Fisher’s Exact tests.
Utilizing the clinical differences found between these
two groups of workers, a new diagnostic case definition (the
MWF-HP Score) was developed. The final model was
selected to fit as closely as possible with the panel opinion,
whilst remaining clinically valid and inclusive. To facilitate
this, each diagnostic element was weighted based on its
positive predictive value forMWF-HP as defined by the panel
opinion. The new scoring system was then applied to the 37
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FIGURE1. Outbreak investigation and worker selection criteria for expert panel review.
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workers, and compared with the EPP. Suitable cut offs for
definite, possible and definitely notMWF-HPwere chosen, to
best match the opinion of the panel.
Validation of MWF-HP Score
The performance of the MWF-HP Score and three other
previously published case definitions were compared by
applying each of them to the 37 workers reviewed [Fox
et al., 1999; Dangman et al., 2002; Robertson et al., 2007].
Performance was assessed by comparing the proportion of
workers correctly identified as definite, possible and
definitely not MWF-HP, against the panel opinion. In an
attempt to externally validate the MWF-HP Score, it was also
applied to 50 previously published US case reports of
workers developing HP due to MWF exposure [Bernstein
et al., 1995; Trout et al., 1996; Kreiss and Cox-Ganser, 1997;
Zacharisen et al., 1998; Fox et al., 1999; Hodgson et al., 2001;
Dangman et al., 2002; Weiss et al., 2002; Trout et al., 2003;
Gupta and Rosenman, 2006]. These cases had previously
been identified during a separate systematic literature review
of all previously published MWF ill health outbreaks [Burton
et al., 2012]. MWF-HP Scores, or the range of possible
scores, were calculated, depending on the level of detail
presented in the case reports.
Ethics Approval
The data utilized in developing the MWF-HP Score was
anonymised, and had been collected as part of a health
investigation carried out by the Health and Safety Executive.
The Birmingham Ethics Committee approved the study to
proceed, and written informed consent from individual
workers was not required.
RESULTS
Participants
The panel classified 14workers as definite cases ofMWF-
HP (all had an EPP of 100%), 12 as possible cases (EPP 20–
80%), and 11 as definitely not cases of MWF-HP (EPP 0–
10%). The reproducibility of the Expert Panel Percentage was
good, with a concordance correlation coefficient of 0.98, with
a mean difference of 5% (range 0–20%). More detail is
provided in the online Supplemental Material.
Demographics of Workers With and
Without MWF-HP
No statistically significant demographic differences were
found between the 14 workers with definite MWF-HP, the
other 23 workers reviewed by the panel, and the remaining
workforce (who had taken part in the original investigation
due to reporting symptoms, but had no clinical suspicion of
MWF-HP). Smoking prevalence was lower amongst those
with definite MWF-HP, but did not reach statistical
significance (Table I).
Significant clinical differences between workers with and
without definite MWF-HP are shown in Table II, and where
available, comparative figures for the remainingworkforce are
also shown. CT findings compatible with HP included
centrilobular nodularity, ground glass, mosaic change, or
established interstitial fibrosis (including usual interstitial
pneumonitis pattern). Biopsy findings compatible with HP
included granulomas, interstitial expansion, lymphocytic
alveolitis, or established usual interstitial pneumonitis [Girard
et al., 2009]. Further details of all of the clinical data com-
parisons can be found in the online Supplemental Material.
Development of MWF-HP Score and Case
Definition
The MWF-HP Score developed is shown in Table III,
where the highest score from each of the five sections is
applied, and then added together up to a maximum of 41
points. Individual scores calculated for each of the 37workers
with suspected MWF-HP in the outbreak are shown in the
online Supplemental Material.
TABLE I. Demographics forWorkersWith andWithout a Definite Diagno-
sis ofMWF-HPAccording to Panel Opinion
Demography
Panel
opinion Number
Mean
(SD) or %
P-value
(definite versus
not definite
MWF-HP)
Age Definite MWF-HP 14 47 (8) 0.19
Not definite MWF-HP 23 43 (8)
Other workers 473 45 (9)
Male Definite MWF-HP 14 86% 0.63
Not definite MWF-HP 23 91%
Other workers 473 92%
Smoker Definite MWF-HP 14 7% 0.22
Not definite MWF-HP 23 26%
Other workers 473 27%
Hours work Definite MWF-HP 14 39 (7) 0.31
Not definite MWF-HP 22 37 (1)
Other workers 469 37 (3)
Year first
employed
Definite MWF-HP 14 1996 (7) 0.31
Not definite MWF-HP 23 1992 (10)
Other workers 464 1992 (9)
Data from the workers who were not suspected as having MWF-HP is shown for
comparison.
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Comparison of Expert Panel Opinion and
MWF-HP Score
There was a good level of correlation between the
derived MWF-HP Score, and the Expert Panel Percentage,
with a Pearson correlation coefficient of 0.85 (P< 0.01). By
using suitable cut offs for the MWF-HP Scores (definite
case> 26, possible case 19–26, and definitely not a
case< 19), it was possible to show agreement (shown in
bold) with the panel opinion in 30/37 (81%) cases (Table IV).
The level of agreement of three other MWF-HP case
definitions with the Expert Panel opinion was 59% [10],
43% [12], and 65% [7].
External Validation
Figure 2 shows the MWF-HP Score, or range of possible
scores, for 50 previously published cases of MWF-HP from a
range of workplaces in the United States [Bernstein et al., 1995;
Trout et al., 1996; Kreiss and Cox-Ganser, 1997; Zacharisen
et al., 1998; Fox et al., 1999; Hodgson et al., 2001; Dangman
et al., 2002; Weiss et al., 2002; Trout et al., 2003; Gupta and
Rosenman, 2006]. In 22/50 of these cases, the MWF-HP Score
or score range would have identified them as a definite HP case.
In the remaining cases it was not possible to assess this for
certain, due to the range of possible scores. Taking themid-point
of the score range as an approximation of the actual MWF-HP
Score, a further 20 cases would also have been identified as
definite MWF-HP. The calculated scores or range of possible
scores for each case are shown in the online Supplemental
Material.
DISCUSSION
Study Findings
This study developed a new case definition for assessing
workers with suspected MWF-HP, based on the evidence-
TABLE II. Clinical Differences BetweenWorkersWith andWithout DefiniteMWF-HPFollowing Panel Review
Clinical data Panel opinion N Result P-value (definite versus not definite MWF-HP)
Previous treatment for your chest (%) Definite MWF-HP 14 100% <0.01
Not definite MWF-HP 23 39%
Other workers 767 19%
Time off with chest illness (%) Definite MWF-HP 14 100% <0.01
Not definite MWF-HP 23 32%
Other workers 768 11%
Unexplained weight loss (%) Definite MWF-HP 14 79% <0.01
Not definite MWF-HP 23 9%
Other workers 764 4%
Breathlessness on exertion MRC 4 (%) Definite MWF-HP 14 93% <0.01
Not definite MWF-HP 23 43%
Other workers 509 8%
Predicted gas transfer factor (%) Definite MWF-HP 14 68% (19) 0.04
Not definite MWF-HP 23 80% (9)
Transfer coefficient (mmol/s/kPa /l) Definite MWF-HP 14 1.4 (0.3) 0.01
Not definite MWF-HP 23 1.7 (0.3)
Total white blood cell count (109/l) Definite MWF-HP 10 8.1 (2.0) 0.03
Not definite MWF-HP 17 6.6 (1.5)
Other workers 91 7.3 (2.3)
Neutrophil count (109/l) Definite MWF-HP 11 5.9 (2.5) <0.05
Not definite MWF-HP 21 4.1 (1.3)
Other workers 107 4.6 (1.9)
a1-antitrypsin (g/l) Definite MWF-HP 11 1.4 (0.1) <0.01
Not definite MWF-HP 20 1.2 (0.2)
Other workers 109 1.2 (0.2)
CTcompatible with HP (%) Definite MWF-HP 14 86% <0.01
Not definite MWF-HP 19 32%
Biopsy compatible with HP (%) Definite MWF-HP 13 62% 0.04
Not definite MWF-HP 5 0
Data from theworkerswhowere not suspected as havingMWF-HP is shown for comparisonwhere available.
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base collected during a large UK outbreak. The generation of
this was novel, in that each diagnostic element was weighted
based on its positive predictive value for HP in the outbreak.
It has been designed to be simple to use, reproducible,
inclusive of different types of clinical presentation, and to
match expert opinion as closely as possible. Although
difficult to truly validate, the MWF-HP Score performed well
both in comparison to other published case definitions, and
when applied to previously published MWF-HP cases from
unrelated outbreaks.
Study Limitations
Due to the lack of a single diagnostic test for HP
[Girard et al., 2009], we used the consensus clinical
opinion of five UK occupational respiratory disease
specialists as our gold standard. Their final opinion was
only made after review of all available clinical information,
and a face-to-face case discussion, aimed at replicating
clinical practice. This opinion showed good reproducibili-
ty, with unanimous agreement among the panel for all of
the definite cases of MWF-HP. The study aimed to be
inclusive and the panel also reviewed cases of suspected
humidifier fever, in order not to miss cases of acute HP,
with similar constitutional symptoms. The main limitation
of the study design was that the panel opinion could only be
based on retrospective review of data documented during
the outbreak investigation and subsequent outpatient
visits, rather than data taken directly and contemporane-
ously from a clinic patient. In particular, there may have
been logistical delays between the workplace investiga-
tion, and obtaining certain hospital investigations (such as
CT scans), which may have affected their predictive value,
if recovery had occurred in that time interval. It is also
possible that in some cases MWF-HP could not be
confirmed by the panel due to a lack of clinical
information, for example, where patients declined certain
tests, or did not attend follow-up appointments.
Another study limitation related to the assumptions
that had to be made in applying other case definitions to the
study population, where the exact wording of symptoms
may have varied, and some of the diagnostic tests
(e.g., gallium scan, alveolar-arterial gradient, and erythro-
cyte sedimentation rate) had not been performed [Fox
et al., 1999; Dangman et al., 2002; Robertson et al., 2007].
This was particularly relevant to the hypersensitivity
pneumonitis diagnostic index (HPDI) [Dangman
et al., 2002], which is likely to have performed better if
the same range of tests had been carried out in the
Powertrain investigation [Robertson et al., 2007].
Finally, the external validation of the MWF-HP Score
was limited by the lack of detail found in some of the
TABLE III. MWF-HP Score forWorkersWith SuspectedMWF-HP
Diagnostic element Score
Respiratory symptoms
Work-related cough/wheeze/
dyspnoea /chest tightness
þ4
Stopping for breath when walking
at own pace on level ground
þ6
Previous time off work with any chest illness þ7
Constitutional symptoms
Recurrent flu-like symptoms worse at the
end of the working week
þ5
Unexplained weight loss þ7
Physiology
FVC< 80% predicted þ3
FVC< 70% predicted and/orTlco< 80% predicted þ5
Tlco< 60% predicted þ10
Radiology/clinical examination
Abnormal CXR (diffuse ground
glass or nodularity)
þ6
Abnormal HRCT (ground glass,
nodularity, mosaic, or UIP pattern)
þ7
Fine end-inspiratory crepitations on auscultation þ7
Evidence of inflammation
Neutrophilia> 7109/l or CRP10 mg/l þ5
BAL lymphocytosis 20% þ8
Lung biopsy typical of HP
(sub-acute HP or usual interstitial pneumonitis)
þ10
Total (max 41)
TABLE IV. Comparison BetweenMWF-HPCase Definitions,Versus Panel
Opinion
Expert panel opinion
Definite Possible Not a case
Fox et al. [1999]
Definite/probable 10 2 0
Possible 3 2 1
Not a case 1 8 10
Dangman et al. [2002]
Definite/probable 6 1 0
Possible 5 1 2
Not a case 3 10 9
Robertson et al. [2007]
Definite/probable 12 2 1
Possible 2 3 1
Not a case 0 7 9
MWF-HP Score
Definite 14 2 0
Possible 0 5 0
Not a case 0 5 11
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published case series from the United States. An exact score
could only be calculated in 4 of the 50 cases, and for the
remainder it was only possible to calculate a range of possible
scores based on the information provided.
Comparison With Other Work
A number of general HP diagnostic criteria are widely
used [Terho, 1986; Richerson et al., 1989; Cormier and
Lacasse, 1996; Schuyler and Cormier, 1997], but little or no
comparative data relating to their validity has been published
[Girard et al., 2009]. The HP Study Group has however
published a prediction rule, applicable to patients presenting
to hospital with possible HP [Lacasse et al., 2003]. The six
significant predictive factors for HP in this study were found
to be; two different symptom patterns; weight loss;
inspiratory crackles; positive precipitins; and exposure to a
known cause. In addition, their study highlighted the
importance of a reduced pulmonary gas transfer in HP
[Girard et al., 2009]. The findings in our study relating to the
high predictive value of unexplained weight loss, and of a
reduced gas transfer in MWF-HP are therefore in keeping
with the findings of this international multi-center cohort
study. The HP prediction rule however was not developed for
use in outbreaks, and is likely to be of limited usefulness
where all workers are exposed to a potential cause. In
addition, standardized serum IgG precipitin testing forMWF-
HP is still in development [Tillie-Leblond et al., 2011].
A number of specific case definitions for MWF-HP have
also been published, following recognition of outbreaks in
exposed workers. The most widely used of these comprised
seven diagnostic elements, resulting in definite (6–7 points),
probable (5 points) and possible (4 points) cases of MWF-HP
[Fox et al., 1999]. The authors compared 34 demographic risk
factors between 18 cases of MWF-HP and 51 controls from
the same workplace, but no clear risk factors were identified.
The authors acknowledged that their conclusions may have
been limited due to the epidemiological case definition not
having been validated prior to usage. The findings in our
study were however in keeping with this study, and unable to
demonstrate clear demographic risk factors for MWF-HP.
A further case definition (the HPDI) was developed from
outbreak data, by comparing data from 16 cases of biopsy
proven MWF-HP, with that from the 14 workers in the
outbreak thought least likely to have the disease [Dangman
et al., 2002]. Perhaps not surprisingly, the workers with
MWF-HP had more symptoms, higher inflammatory
markers, lower gas transfers, higher alveolar-arterial oxygen
gradients, lower vital capacities, more abnormal CT scans,
and more abnormal gallium scans. The analysis in our study
was broadly similar in principal, although we used the more
inclusive panel clinical opinion (which included biopsy
findings where available) as our gold standard for MWF-HP
diagnosis. Our study comparison groups were also different,
as we used a more clinically relevant scenario, looking for
clinical differences between workers with definite MWF-HP,
and workers without definite MWF-HP (many having
occupational asthma or humidifier fever), within a group
who had all previously been suspected of having HP during
an outbreak investigation. As a result of this, our study found
FIGURE2. MWF-HP Scores (or score range) for 50 US workers with HP due to MWF.
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less marked differences in symptoms between the two groups
of workers, with the only statistically significant differences
being for MRC Grade 4 breathlessness, and unexplained
weight loss. Other constitutional symptoms such as fever,
shivering, tiredness, weakness, joint, or muscle pains were
not predictive of MWF-HP within the group studied, as these
symptoms were also common in the other workers.
Dangman et al. [2002] found elevated levels of
erythrocyte sedimentation rate (ESR) in workers with
MWF-HP, but not neutrophil count or c-reactive protein
(CRP). ESR was not measured during the UK outbreak, but
we did find significantly higher mean levels of total white cell
and neutrophil counts in workers with MWF-HP. Although
mean CRP was also higher in the workers with MWF-HP, it
was only available in half of the workers studied, and the lack
of a significant difference may reflect a type 2 error. The
clinical findings in sub-acute HPmay varywith exposure, and
the most useful marker of inflammation in an outbreak is
likely to be dependant on the logistics of where and when the
blood sampling takes place (e.g., workplace versus outpatient
clinic), based on ease of processing, and the half-life of the
inflammatory marker selected.
The diagnostic criteria selected byDangman et al. [2002]
were designed to avoid the need for invasive biopsies, and
were based on scoring points for; symptoms; crackles;
abnormal pulmonary physiology; raised inflammatory
markers; and abnormal radiology (on CXR, CT, or gallium
scan). This formed the basis of the HPDI Score with 6–9
being a definite case, 4–5 a probable case, and 3 a possible
case. Although similar in concept to the Fox criteria [Fox
et al., 1999], Dangman et al. [2002] applied some weighting
to two of the criteria, so that more abnormal results
contributed twice as many points to the total. They also
attempted to validate the HPDI by applying it to the other 31
workers from their outbreak, and demonstrating that their
case definition agreed with that developed by Fox et al.
[1999] in 55 of the 61 workers. The lack of an agreed “gold
standard” method of diagnosis in HP however, makes any
form of validation difficult.
The diagnostic criteria in our study were more heavily
weighted, based on their positive predictive value for MWF-
HP (range 30–100%), giving each a possible score of 3–10.
The diagnostic elements selected were chosen to be as
inclusive as possible, including both invasive and non-
invasive test results, and aimed at identifying the full range of
possible types of HP. As examples, exertional breathlessness
was included to identify workers with chronic HP (without
work-related respiratory symptoms), and the recurrent flu-
like symptom category was modified to avoid identifying
workers with humidifier fever. Additional criteria were also
utilized, as we identified that workers with MWF-HP
frequently reported having had to take time off work due
to chest illnesses and/or had required treatment for chest
problems in the 12–18 months prior to the recognition of the
outbreak. The remainder of the diagnostic elements selected
in the MWF-HP Score were selected to reflect the usual
clinical tests performed in investigating this disease, and
considering the findings from other investigators [Fox
et al., 1999; Dangman et al., 2002; Lacasse et al., 2003;
Girard et al., 2009]. By setting suitable cut offs in the MWF-
HP Score, it was possible to show agreement with the panel
opinion in 81% of cases. As expected, given that the criteria
were generated by the data, this level of agreement was much
better than with the other published criteria. We therefore
attempted to externally validate the MWF-HP Score by
applying it to all MWF-HP cases from other published
outbreaks. Although limited by the detail provided in
published case series, the MWF-HP Score appeared to
perform well, as applied to 50 US cases from 9 different
outbreaks.
Study Implications
Investigating any ill health outbreak in large workplaces
is logistically challenging, due to the unexpected nature of the
outbreak, and the need to screen a large number of workers in
a short period [Barber et al., 2012]. This study has developed
and attempted to validate a new case definition for HP, and
although it has been developed using data from workers
exposed toMWFs, it may also be useful in other similar types
of HP outbreaks [Ganier et al., 1980; Rose et al., 1998;
Iossifova et al., 2011].
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